HALOZYME THERAPEUTICS

Halozyme Therapeutics is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the insulin, cancer, dermatology and drug delivery markets. The company's product portfolio is based primarily on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix. Halozyme's Enhanze(TM) technology is a novel drug delivery platform designed to increase the absorption and di... spersion of biologics. The company has key partnerships with Roche, Baxter, ViroPharma and Intrexon to apply Enhanze technology to therapeutic biologics including HerceptinÂ®, MabTheraÂ®, immunoglobulin, CinryzeÂ® and alpha 1-antitrypsin. Halozyme's Ultrafast Insulin program combines its rHuPH20 enzyme with mealtime insulins, which may produce more rapid absorption, faster action, and improved glycemic control. The product candidates in Halozyme's pipeline target multiple areas of significant unmet medical need.

#SimilarOrganizations #People #Financial #Event #Website #More

HALOZYME THERAPEUTICS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Marketing Medical

Founded:

1998-01-01

Address:

San Diego, California, United States

Country:

United States

Website Url:

http://www.halozyme.com

Total Employee:

101+

Status:

Active

Contact:

858.794.8889

Email Addresses:

[email protected]

Total Funding:

245 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Tag Manager WordPress Wordpress Plugins Organization Schema IPv6 ReCAPTCHA Cloudflare JS

Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

dice-therapeutics-logo

Dice Therapeutics

Dice Therapeutics develops a transformative platform designed for the discovery of novel small molecules.

lexicon-pharmaceuticals-logo

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals is a biopharmaceutical company that discovers and develops precise medicines for human disease.

Current Advisors List

kathryn-e-falberg_image

Kathryn E. Falberg Board of Directors @ Halozyme Therapeutics
Board_member

randal-j-kirk_image

Randal J. Kirk Board of Directors @ Halozyme Therapeutics
Board_member

Current Employees Featured

ben-hickey_image

Ben Hickey
Ben Hickey Chief Financial Officer @ Halozyme Therapeutics
Chief Financial Officer
2022-02-01

mas-matsuda_image

Mas Matsuda
Mas Matsuda Chief Compliance Officer @ Halozyme Therapeutics
Chief Compliance Officer

becky-tanamachi_image

Becky Tanamachi
Becky Tanamachi Executive Director @ Halozyme Therapeutics
Executive Director

daniel-sauder_image

Daniel Sauder
Daniel Sauder Senior Consultant @ Halozyme Therapeutics
Senior Consultant
2009-01-01

michael-j-labarre_image

Michael J LaBarre
Michael J LaBarre Chief Technical Officer @ Halozyme Therapeutics
Chief Technical Officer

elaine-sun_image

Elaine Sun
Elaine Sun SVP and Chief Financial Officer @ Halozyme Therapeutics
SVP and Chief Financial Officer
2020-02-01

kurt-gustafson_image

Kurt Gustafson
Kurt Gustafson Vice President, CFO @ Halozyme Therapeutics
Vice President, CFO

steve-knowles_image

Steve Knowles
Steve Knowles Chief Medical Officer @ Halozyme Therapeutics
Chief Medical Officer

helen-torley_image

Helen Torley
Helen Torley Chief Executive Officer, President @ Halozyme Therapeutics
Chief Executive Officer, President

jake-beverage_image

Jake Beverage
Jake Beverage Senior Director, Alliance and Program Management @ Halozyme Therapeutics
Senior Director, Alliance and Program Management
2019-12-01

Founder

gregory-frost_image

Gregory Frost

Stock Details

Company's stock symbol is NASDAQ:HALO

Acquisitions List

Date	Company	Article	Price
2022-04-13	Antares Pharma	Antares Pharma acquired by Halozyme Therapeutics	960 M USD

Investors List

janssen-biotech_image

Key Employee Changes

Date	New article
2022-02-02	Halozyme Appoints New Chief Financial Officer
2020-02-24	Halozyme Announces CFO Transition

Official Site Inspections

http://www.halozyme.com Semrush global rank: 3.28 M Semrush visits lastest month: 5 K

Host Informations
Whois Informations

Loading ...